The Biden administration announced on June 21 how it would allocate 55 million of the 80 million doses from its vaccine supply to other countries. It is not clear how many doses India will get in this second allocation.
The administration already outlined its plan to share the first 25 million doses of its stockpile bilaterally and through COVID-19 Vaccine Global Access, abbreviated as COVAX — Vaccines Distributed Globally.
An international alliance to Of the 80 million, three quarters are being shared through COVAX, and a quarter is being shared directly. Of the 80 million, 60 million are AstraZeneca vaccines that have not yet been released in the U.S. has not been approved for use in.
(ads2)
Of the 55 million doses, 41 million will be shared through COVAX. Of this, about 14 million will go to Asian countries, including India, some 10 million to Africa (coordinated by the African Union), and about 16 million to Latin American countries.
The White House statement said another 14 million doses would be shared "with regional priorities and other recipients." It includes African, Asian, Eastern European, and South American countries as well as three South Asian countries – Afghanistan, Bangladesh, and Pakistan.
The White House said the specific number of vaccines will be determined and shared as the administration works through the logistical and regulatory specifics for each region.
Last week at the G7 in the UK, President Joe Biden announced that the US would buy and donate 500 million doses of the Pfizer-BioNTech vaccine to low- and middle-income countries.
The G7 is also committed to providing a total of 1 billion vaccine doses since this summer. The World Health Organization (WHO) has estimated that the world needs 11 billion vaccines to end the pandemic.
Posts
